Literature DB >> 18281695

Epigenetics: what is it and why is it important to mental disease?

Anthony R Isles1, Lawrence S Wilkinson.   

Abstract

INTRODUCTION: The chemical marking of the DNA and surrounding histone proteins represent some of the means by which gene expression is controlled. Many of these epigenetic modifications are pre-programmed and are an important part of the control of development. SOURCES OF DATA: There is an accumulating body of evidence from clinical genetics and animal work that suggests some epigenetic processes may also be labile. AREAS OF AGREEMENT: A number of these studies have demonstrated that the epigenetic status of genes can be altered through environmental events such as in vitro culture of embryos and exposure to toxins, sometimes resulting in disease. AREAS OF CONTROVERSY: More routine variations in life events may also be encoded by changes in the epigenetic status of genes, and as such these processes may provide a mechanism mediating interplay between genes and the environment, including the now recognized idea of gene-environment interactions. GROWING POINTS AND AREAS TIMELY FOR DEVELOPING RESEARCH: The significance of epigenetics for mental disease is becoming increasingly clear. It is important that the techniques developed to analyse the epigenome are now applied to the study of the molecular basis of mental disease to assess the contribution of gene-environment interactions to brain function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281695     DOI: 10.1093/bmb/ldn004

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  9 in total

1.  Schizophrenia and birthplace of paternal and maternal grandfather in the Jerusalem perinatal cohort prospective study.

Authors:  S Harlap; M C Perrin; L Deutsch; K Kleinhaus; S Fennig; D Nahon; A Teitelbaum; Y Friedlander; D Malaspina
Journal:  Schizophr Res       Date:  2009-04-09       Impact factor: 4.939

Review 2.  The prevention of schizophrenia--what can we learn from eco-epidemiology?

Authors:  James B Kirkbride; Peter B Jones
Journal:  Schizophr Bull       Date:  2010-10-25       Impact factor: 9.306

3.  The molecular genetics of autism spectrum disorders: genomic mechanisms, neuroimmunopathology, and clinical implications.

Authors:  Daniel J Guerra
Journal:  Autism Res Treat       Date:  2011-05-17

4.  Protocadherin 11X/Y a human-specific gene pair: an immunohistochemical survey of fetal and adult brains.

Authors:  Thomas H Priddle; Tim J Crow
Journal:  Cereb Cortex       Date:  2012-06-28       Impact factor: 5.357

Review 5.  Psychotherapy and Genetic Neuroscience: An Emerging Dialog.

Authors:  Juan P Jiménez; Alberto Botto; Luisa Herrera; Caroline Leighton; José L Rossi; Yamil Quevedo; Jaime R Silva; Felipe Martínez; Rodrigo Assar; Luis A Salazar; Manuel Ortiz; Ulises Ríos; Paulina Barros; Karina Jaramillo; Patrick Luyten
Journal:  Front Genet       Date:  2018-07-17       Impact factor: 4.599

Review 6.  Epigenetics, chromatin and brain development and function.

Authors:  Anthony R Isles
Journal:  Brain Neurosci Adv       Date:  2018-11-12

7.  Early life stress during the neonatal period alters social play and Line1 during the juvenile stage of development.

Authors:  Amelia Cuarenta; Stacey L Kigar; Ian C Henion; Liza Chang; Vaishali P Bakshi; Anthony P Auger
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

Review 8.  Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects.

Authors:  Ma'mon M Hatmal; Mohammad A I Al-Hatamleh; Amin N Olaimat; Walhan Alshaer; Hanan Hasan; Khaled A Albakri; Enas Alkhafaji; Nada N Issa; Murad A Al-Holy; Salim M Abderrahman; Atiyeh M Abdallah; Rohimah Mohamud
Journal:  Biomedicines       Date:  2022-05-24

Review 9.  Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative Diseases.

Authors:  Bhairavi Srinageshwar; Panchanan Maiti; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.